Protagonist receives FDA approval for psoriasis drug ICOTYDE

March 18, 2026 8:05 AM

The U.S. Food and Drug Administration approved ICOTYDE (icotrokinra) for treating moderate to severe plaque psoriasis in adults and pediatric ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found